对癌症免疫反应二分法的建模:细胞毒性效应和促肿瘤炎症
Modeling the Dichotomy of the Immune Response to Cancer: Cytotoxic Effects and Tumor-Promoting Inflammation
摘要:
虽然免疫反应通常被认为是抑制肿瘤生长的作用,但现在很清楚,它既可以是刺激性的,也可以是抑制性的。这些相互竞争的影响之间的相互作用对肿瘤的发展和癌症的休眠有着复杂的影响。为了从理论上研究这种生物学现象,我们构建了一个最小参数化的框架,该框架包含了免疫反应的各个方面。我们将所有免疫细胞类型的影响,自限性逻辑生长的一般原则以及炎症的物理过程结合到一个定量环境中。模拟表明,虽然存在分别以较大或较小的最终肿瘤体积为特征的促肿瘤或抗肿瘤免疫原性应答,但每种应答都涉及初始期,其中肿瘤生长被刺激超过没有免疫应答的生长。数学描述是不可识别的,这使我们能够捕获肿瘤生长中的固有生物学变异性,这些变异性可以显著改变肿瘤免疫动力学,从而改变治疗成功率。该模型预测肿瘤生长的免疫调节的能力可以为设计新的治疗方法提供模板,这些治疗方法利用免疫应答来改善肿瘤抑制,包括免疫诱导的休眠状态的潜在实现。
英文摘要:
Although the immune response is often regarded as acting to suppress tumor growth, it is now clear that it can be both stimulatory and inhibitory. The interplay between these competing influences has complex implications for tumor development and cancer dormancy. To study this biological phenomenon theoretically we construct a minimally parameterized framework that incorporates all aspects of the immune response. We combine the effects of all immune cell types, general principles of self-limited logistic growth, and the physical process of inflammation into one quantitative setting. Simulations suggest that while there are pro-tumor or antitumor immunogenic responses characterized by larger or smaller final tumor volumes, respectively, each response involves an initial period where tumor growth is stimulated beyond that of growth without an immune response. The mathematical description is non-identifiable which allows us to capture inherent biological variability in tumor growth that can significantly alter tumor-immune dynamics and thus treatment success rates. The ability of this model to predict immunomodulation of tumor growth may offer a template for the design of novel treatment approaches that exploit immune response to improve tumor suppression, including the potential attainment of an immune-induced dormant state.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。